Thomas Musci

Thomas Musci, MD is currently the Chief Medical Officer At Deepcell Inc. He served as Chief Medical Officer and Vice President of Clinical Development and Medical Affairs at Ariosa Diagnostics (acquired by Roche), a molecular diagnostics testing service provider of non-invasive prenatal testing using cell-free DNA technology. Dr. Musci spent 22 years on faculty at the University of California, San Francisco (UCSF).

Dr. Musci has served as the Chair of the Genetics Committee for the American Congress of Obstetricians and Gynecologists (ACOG) and a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics. Dr. Musci earned his medical degree at the Georgetown University School of Medicine and completed his Obstetrics and Gynecology residency, Maternal-Fetal Medicine fellowship, Medical Genetics Fellowship, and post-doctoral fellowship all at UCSF.